Insulet Artificial Pancreas Free-Living IDE3

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

May 28, 2019

Study Completion Date

May 28, 2019

Conditions
Type1 Diabetes Mellitus
Interventions
DEVICE

Insulet automated glucose control system

Insulet AP (artificial pancreas) system, using the Omnipod® insulin management system, Dexcom G4Share® AP System and personalized model predictive control algorithm.

Trial Locations (3)

80045

University of Colorado Denver, Denver

94305

Stanford University, Palo Alto

06511

Yale University School of Medicine, New Haven

Sponsors
All Listed Sponsors
lead

Insulet Corporation

INDUSTRY

NCT03216460 - Insulet Artificial Pancreas Free-Living IDE3 | Biotech Hunter | Biotech Hunter